Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
188 participants
OBSERVATIONAL
2021-01-19
2023-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Evaluation of the OtoSight
NCT03890107
Validating and AI Software for Assessment of Children With Ear Concerns
NCT07243093
Diagnostic Utility of Otosight Middle Ear Scope
NCT05641285
SWIR Otoscopy Study
NCT06944795
Coherent Optical Detection of Middle Ear Disease
NCT05353569
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pediatric patients with possible ear infections
Pediatric patients presenting with otitis media (acute otitis media or otitis media with effusion) will be imaged with the PhotoniCare OtoSight.
PhotoniCare OtoSight Middle Ear Scope
PhotoniCare OtoSight imaging using a near-infrared laser
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PhotoniCare OtoSight Middle Ear Scope
PhotoniCare OtoSight imaging using a near-infrared laser
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
6 Months
4 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Pittsburgh
OTHER
National Institute on Deafness and Other Communication Disorders (NIDCD)
NIH
PhotoniCare, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ryan Shelton, PhD
Role: PRINCIPAL_INVESTIGATOR
PhotoniCare, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
000002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.